Status:
COMPLETED
Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients
Lead Sponsor:
University of Iceland
Collaborating Sponsors:
University of Aarhus
Conditions:
Depression, Anxiety
Eligibility:
All Genders
18-67 years
Phase:
NA
Brief Summary
This study is done to evaluate the effects of Mindfulness Based Cognitive Therapy (MBCT) for primary care patients that have mild to moderate symptoms of depression and anxiety. Half of the study part...
Detailed Description
Patients that show mild to moderate symptoms of depression and anxiety are common in the primary care setting. These patients are often treated with antidepressant or anxiolytic medication instead of ...
Eligibility Criteria
Inclusion
- PHQ-9 and GAD-7 score 5-14 points
- Age18 - 67
- No current/recent psychotherapy of any kind other than his/hers physicians therapy( can be taking antidepressants but not in CBT)
- No regular meditation or yoga practice
- Not mentally retarded
- Speaks and understands Icelandic
- No current substance dependence
- Not diagnosed with schizophrenic symptoms or bipolar disease that that currently requires treatment
- Not participating in another mental health study
Exclusion
- Age: \<18 and \>67 years old.
- Severe psychiatric symptoms requiring psychiatric care
- Risk of suicide
- Inability to participate in group sessions because of severe substance misuse;
- Inability to speak and understand Icelandic
- Pregnancy;
- Current psychotherapy of any kind;
- Participation in any other psychiatric intervention study;
- Thyroid disease (if newly diagnosed by the doctor).
- Score under 5 on both GAD7 and PHQ-9 and score over 14 on either GAD7 or PHQ-9.
- One or more of the following ICD-10 psychiatric diagnoses:
- F00-F09 Organic, including symptomatic, mental disorders F10-F19 Mental and behavioural disorders due to psychoactive substance use F20-F29 Schizophrenia, schizotypal and delusional disorders F70-F79 Mental retardation
- \-
Key Trial Info
Start Date :
September 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 21 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03272516
Start Date
September 12 2017
End Date
October 21 2020
Last Update
November 4 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Heilsugæslan Grafarvogi
Reykjavik, Grafarvogur, Iceland, 112
2
Heilsugæslan Miðbæ
Reykjavik, Iceland, 101